In fact, they describe the process we define “effector-to-regulatory CD8+ T cell transition”, which determines both the loss of effector activities and the acquisition of regulatory properties by effector CD8+ T cells infiltrating HNSCC. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.